Nucleus (Healthcare Technology Systems) Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$2M
- Investors
-
44
Nucleus (Healthcare Technology Systems) General Information
Description
Operator of a biotechnology research platform intended to offer next-generation consumer genetic testing and analysis. The company's platform integrates comprehensive genomic sequencing, detailed health reports, and actionable insights based on a deeper DNA analysis compared to industry standards, enabling individuals to understand their genetic predispositions better, monitor health risks, and make informed lifestyle and medical decisions for long-term health management.
Contact Information
Website
www.mynucleus.comCorporate Office
- 8000 Norman Center Drive
- Bloomington, MN 55437
- United States
Corporate Office
- 8000 Norman Center Drive
- Bloomington, MN 55437
- United States
Nucleus (Healthcare Technology Systems) Timeline
Nucleus (Healthcare Technology Systems) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 04-Aug-2026 | $2M | In Progress | Generating Revenue | ||
| 5. Later Stage VC | Completed | Generating Revenue | ||||
| 4. Early Stage VC (Series A) | 30-Jan-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 24-Jun-2024 | Completed | Startup | |||
| 2. Seed Round | 14-Jan-2023 | $14M | $17.5M | Completed | Startup | |
| 1. Seed Round | 01-Jan-2022 | $3.5M | $3.5M | Completed | Startup |
Nucleus (Healthcare Technology Systems) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-8 | ||||||||
| Seed-7 | ||||||||
| Seed-6 | ||||||||
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 3,009,792 | $0.000010 | $0.07 | $0.07 | 1x | $0.07 | 28.97% | |
| Seed | 2,718,920 | $0.000010 | $5.15 | $5.15 | 1x | $5.15 | 0.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Nucleus (Healthcare Technology Systems) Comparisons
Industry
Financing
Details
Nucleus (Healthcare Technology Systems) Competitors (2)
One of Nucleus (Healthcare Technology Systems)’s 2 competitors is Ambry Genetics, a Formerly PE-Backed company based in Aliso Viejo, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ambry Genetics | Formerly PE-Backed | Aliso Viejo, CA | ||||
| GEDmatch | Formerly PE-Backed | Germantown, MD |
Nucleus (Healthcare Technology Systems) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nucleus (Healthcare Technology Systems) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nucleus (Healthcare Technology Systems) Investors (44)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Asylum Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Giant Step Capital | Venture Capital | Minority | ||
| Later Capital | Venture Capital | Minority |
Nucleus (Healthcare Technology Systems) Acquisitions (2)
Nucleus (Healthcare Technology Systems)’s most recent deal was a Merger/Acquisition with Cambrean. The deal was made on 30-Jan-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cambrean | 30-Jan-2025 | Merger/Acquisition | Information Services (B2C) | ||
| Impute.me | 14-Jul-2022 | Merger/Acquisition | Other Healthcare Technology Systems |
Nucleus (Healthcare Technology Systems) Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cambrean | San Francisco, CA | 2021 |
Nucleus (Healthcare Technology Systems) FAQs
-
When was Nucleus (Healthcare Technology Systems) founded?
Nucleus (Healthcare Technology Systems) was founded in 2021.
-
Where is Nucleus (Healthcare Technology Systems) headquartered?
Nucleus (Healthcare Technology Systems) is headquartered in Bloomington, MN.
-
What is the size of Nucleus (Healthcare Technology Systems)?
Nucleus (Healthcare Technology Systems) has 42 total employees.
-
What industry is Nucleus (Healthcare Technology Systems) in?
Nucleus (Healthcare Technology Systems)’s primary industry is Other Healthcare Technology Systems.
-
Is Nucleus (Healthcare Technology Systems) a private or public company?
Nucleus (Healthcare Technology Systems) is a Private company.
-
What is Nucleus (Healthcare Technology Systems)’s current revenue?
The current revenue for Nucleus (Healthcare Technology Systems) is .
-
How much funding has Nucleus (Healthcare Technology Systems) raised over time?
Nucleus (Healthcare Technology Systems) has raised $31.5M.
-
Who are Nucleus (Healthcare Technology Systems)’s investors?
, Asylum Ventures, , Giant Step Capital, and Later Capital are 5 of 44 investors who have invested in Nucleus (Healthcare Technology Systems).
-
Who are Nucleus (Healthcare Technology Systems)’s competitors?
Ambry Genetics and GEDmatch are competitors of Nucleus (Healthcare Technology Systems).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
